Dihexa
Dihexa
Also known as: PNB-0408, Hepatocyte Growth Factor Mimetic
Overview
Key Facts
Primary Goal: A synthetic hexapeptide analog of angiotensin IV, developed at Washington State University
A synthetic hexapeptide analog of angiotensin IV, developed at Washington State University. Extraordinarily potent cognitive enhancer and neuroprotective agent, reported to be 10 million times more potent than BDNF at promoting synaptic connectivity. Half-Life ~6 hours (estimated) Typical Dose 10–40 mg Frequency 1x daily (oral or intranasal) Cycle Length 2-4 weeks, with breaks
Dosing Information
Half-Life
~6 hours (estimated)
Typical Dose
10–40 mg
Frequency
1x daily (oral or intranasal)
Cycle Length
2-4 weeks, with breaks
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Developed by Dr. Joseph Harding and colleagues at Washington State University. Published preclinical data demonstrates remarkable cognitive enhancement in scopolamine-impaired and aged rats. No human clinical trials completed. Patent filed for neurodegenerative disease applications. Safety profile in humans remains uncharacterized.
Frequently Asked Questions
Common questions about Dihexa
UK-Specific Information
Exclusive data points and guidance for UK residents using Dihexa
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.